The powerful new tools of genetic investigation are steadily expanding our understanding of the molecular basis of inherited neurological disease. This is particularly so in the context of the inherited ataxias, in which nosological difficulties are beginning to be resolved by a genetically based classification. Harnessing the new knowledge will bring further rewards, including molecular genetic diagnosis, definition of clinical phenotypes, elucidation of pathophysiology, and the possibility of new treatments.
Many metabolic disorders include ataxia as a more or less prominent feature. Traditionally it has been useful to distinguish these disorders from the "idiopathic" inherited ataxias, although the distinction is already seeming artificial as pathological mechanisms are elucidated. This review considers the impact of the new knowledge on the inherited ataxias previously considered idiopathic.
Classification of the idiopathic inherited ataxias Although pathological study has provided insights into the anatomy and pathophysiology of the ataxias, pathologically based classifications have proved unsatisfactory when clinical features and inheritance (and recently, molecular genetic data) are not considered. With some exceptions, clinical criteria alone are also inadequate, as there may be discordance even between affected ataxic siblings in fea- Table 1 The idiopathic inherited ataxias (derivedfrom Harding') Idiopathic ataxias either known or thought to be autosomal recessive The X25 gene product, termed frataxin, contains 210 amino acids. The gene comprises six exons, with evidence of alternate splicing. There is no resemblance to other known genes, and as yet it is not possible to predict the function of frataxin. Northern blots show that X25 expression is high in the heart, with intermediate levels in the liver, skeletal muscle, and pancreas, and minimal levels in other tissues, including whole brain. Comparison between CNS tissues showed high expression in the spinal cord, less in the cerebellum, and very little in the cerebral cortex. Messenger RNA concentrations were undetectable or extremely low in patients with Friedreich's ataxia, suggesting that the mutation causes interference in transcription or RNA processing. Reduced frataxin in the heart and Trinucleotide repeats are unstable, with variation in repeat number within tissues and on gametogenesis. Anticipation refers to the propensity for earlier onset and increased severity of disease in succeeding generations. Molecularly this arises from a propensity for the repeat to expand in gametogenesis. Male gametogenesis is more likely to result in repeat expansion than female gametogenesis, explaining the second finding, of severe phenotypes being more often the result of paternal transmission. In the case of SCA1, maternal transmission results in an average decrease of 0 4 repeats, whereas paternal transmission results in an average increase of 3.3 repeats. 39 The SCAl triplet has a further intriguing characteristic. there is also a parental sex effect with paternal transmission showing a larger increase (about three repeats) than female transmission (about one repeat)."5 52 At necropsy patients diagnosed as having MachadoJoseph disease have predominant involvement of the spinocerebellar tracts, Clarke's column nuclei, vestibular nuclei, and pontine base.53 Diirr et al studied two patients with SCAI and two patients with SCA3/MJD at necropsy.54 Whereas some features were in common they thought that the SCA3/MJD pathology could be distinguished by the presence of lesions in the internal pallidum and interomediolateral columns and lack of inferior olive and Purkinje cell degeneration. Whether using clinical or pathological criteria,' 63 there is general agreement that this ADCA is distinguished from others by the presence of a pigmentary macular dystrophy. Enevoldson and colleagues described 54 members of eight families. 64 The presenting symptom was ataxia in two thirds of patients and visual failure or both in the remainder. The retinal abnormalities are often subtle. Other neurological features include pyramidal signs and a supranuclear ophthalmoplegia. Onset varied between six months and 60 years with more rapid progression usually seen in early onset cases. Some obligate gene carriers were asymptomatic. Anticipation in the offspring of affected fathers was noted; all infantile onset cases resulted from paternal transmission. Therefore, both clinical and laboratory data support the possibility of the gene mutation being an unstable trinucleotide expansion.59
The ADCA type II locus has been mapped to chromosome 3p1 2-p2 1 1 
